Manufacturer record
Zee Laboratories Ltd. Behind 47: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
11 batches manufactured by Zee Laboratories Ltd. Behind 47 (Himachal Pradesh) were declared Not of Standard Quality between July 2021 and February 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: 425-1598, Nicorandil Tablets I.P. 5 mg (exp Jun 2027). CDTL, Hyderabad (CDSCO lab) found it not of standard quality: The sample received does not conform to I.P. 2022 specification with respect to the tests for Dissolution and Assay only. Listed in the February 2026 alert.
Records by type
11 records linked to Zee Laboratories Ltd. Behind 47 in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Nicorandil Tablets I.P. 5 mg | Batch 425-1598Mfg Jul 2025 · Exp Jun 2027 | The sample received does not conform to I.P. 2022 specification with respect to the tests for Dissolution and Assay only.Assay | CDTL, HyderabadCDSCO lab | Feb 2026 |
| Piperacillin and Tazobactam Injection I.P. 4.5 gm | Batch 325-1088Mfg Aug 2025 · Exp Jul 2027 | The sample does not conform to claim as per IP 2022 in respect to The Test of Particulate matterParticulate matter | RDTL, ChandigarhCDSCO lab | Dec 2025 |
| Piperacillin and Tazobactam Injection I.P. 4.5 gm | Batch 325-1090Mfg Aug 2025 · Exp Jul 2027 | The sample does not conform to claim as per IP 2022 in respect to The Test of Particulate matter.Particulate matter | RDTL, ChandigarhCDSCO lab | Dec 2025 |
| Sodium Valproate Gastro-resistant Tablets I.P. 200 mg. | Batch 425-263Mfg Jan 2025 · Exp Dec 2026 | The sample is not of standard quality for the reason stated under "Description" of the tablets.Description | RDTL, GuwahatiCDSCO lab | Nov 2025 |
| Itraconazole Capsule IP 100mg | Batch 1725-230Mfg Apr 2025 · Exp Sep 2027 | The sample does not conforrm to the IP with respect to DissolutionDissolution | DTL, JaipurState lab | Nov 2025 |
| Clopidogrel and Aspirin Tablets IP (75 mg/75 mg) | Batch Z24-293Mfg Apr 2024 · Exp Mar 2026 | The sample does not conform to I.P with respect to DissolutionDissolution | CDL, KolkataCDSCO lab | Oct 2025 |
| Amoxycillin & Potassium Clavulanate Injection I.P. | Batch 324-869Mfg Jul 2024 · Exp Jun 2026 | The sample does not conform to claim as per I.P. 2022 with respect to the test for "Assay" of Amoxycillin and Clavulanic Acid.Assay | RDTL, GuwahatiCDSCO lab | Oct 2025 |
| Clopidogrel & Aspirin Tablets I.P. (75 mg & 75 mg) | Batch Z24-338Mfg May 2024 · Exp Apr 2026 | sample does not conform to I.P with respect to the test for Dissolution (Clopidogrel).Dissolution | CDTL, IndoreCDSCO lab | Sep 2025 |
| Tobramycin Ophthalmic Solution USP 0.3% w/v | Batch Z24-506Mfg Jul 2024 · Exp Jun 2026 | Assay of TobramycinAssay | CDL, KolkataCDSCO lab | Aug 2025 |
| Amikacin Sulphate Injection IP 500mg/2ml | Batch 325-179Mfg Feb 2025 · Exp Jan 2027 | Particulate matter and DescriptionDescription | CDL, KolkataCDSCO lab | Aug 2025 |
| (Levoziv -500) Levofloxacin Tablets I.P. 500 mg | Batch 420-1087Mfg Jul 2020 · Exp Jun 2023 | DissolutionDissolution | RDTL GuwahatiState lab | Jul 2021 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.